- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SBT Ultrasonic Technology Co Ltd (688392)
"SBT Ultrasonic Technology Co Ltd stock price live, this page displays SS 688392 stock exchange data. View the 688392 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SBT Ultrasonic Technology Co Ltd real time stock price chart below.
What Is the SBT Ultrasonic Technology Co Ltd Stock Price Today?
The SBT Ultrasonic Technology Co Ltd stock price today is 51.67.
What Is the Stock Symbol for SBT Ultrasonic Technology Co Ltd?
The stock symbol for SBT Ultrasonic Technology Co Ltd is ""688392.""
What Stock Exchange Does SBT Ultrasonic Technology Co Ltd Trade On?
SBT Ultrasonic Technology Co Ltd is listed and trades on the Shanghai stock exchange.
Is SBT Ultrasonic Technology Co Ltd a Good Stock to Buy?
Determining whether SBT Ultrasonic Technology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688392 quote. (ISIN: CNE100005P15)"
What Is the SBT Ultrasonic Technology Co Ltd Stock Price Today?
The SBT Ultrasonic Technology Co Ltd stock price today is 51.67.
What Is the Stock Symbol for SBT Ultrasonic Technology Co Ltd?
The stock symbol for SBT Ultrasonic Technology Co Ltd is ""688392.""
What Stock Exchange Does SBT Ultrasonic Technology Co Ltd Trade On?
SBT Ultrasonic Technology Co Ltd is listed and trades on the Shanghai stock exchange.
Is SBT Ultrasonic Technology Co Ltd a Good Stock to Buy?
Determining whether SBT Ultrasonic Technology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688392 quote. (ISIN: CNE100005P15)"
Shanghai
Currency in CNY
51.67
+0.87(+1.71%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.12
53.12
52 wk Range
27.78
61.50
688392 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688392 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.1253.12
52 wk Range
27.7861.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688392 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
22.61
Downside
-56.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
SBT Ultrasonic Technology Co Ltd Company Profile
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China. The company develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom’s macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. It also developing ICP-192, a pan-FGFR inhibitor that is in a Phase I/II clinical trial for the treatment of solid tumor patients, including cholangiocarcinoma, and head and neck cancer; ICP-723, a pan-TRK inhibitor, which is in Phase I clinical trial to treat neurotrophic tyrosine receptor kinase fusion positive cancers; ICP-332, a novel tyrosine kinase 2 inhibitor that is in a Phase I clinical trial for the treatment of autoimmune diseases; and ICP-B02, a bispecific antibody for the treatment of lymphoma. In addition, the company develops ICP-189 and ICP-B03 for the treatment of solid tumors; ICP-033 to treat liver cancer, renal cell carcinoma, colorectal cancer, and other solid tumors; ICP-488 for the treatment of autoimmune diseases; ICP-B05, an anti-CC chemokine receptor 8 monoclonal antibody for the treatment of various cancers; ICP-248 to treat hematology; and ICP-490 for the treatment of hematology and autoimmune diseases. Further, the company offers ICP-B04 (Tafasitamab) to treat DLBCL/hematology. The company has a clinical collaboration with ArriVent Biopharma, Inc. to evaluate the anti-tumor activity and safety of ICP-189 combined with furmonertinib in patients with advanced non-small cell lung cancer. InnoCare Pharma Limited was incorporated in 2015 and is headquartered in Beijing, China.
Compare 688392 to Peers and Sector
Metrics to compare | 688392 | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship Relationship688392PeersSector | |
|---|---|---|---|---|
P/E Ratio | −73.2x | −20.3x | −0.4x | |
PEG Ratio | −2.80 | 0.32 | 0.00 | |
Price/Book | 3.0x | 5.9x | 2.6x | |
Price / LTM Sales | 16.7x | 9.6x | 2.9x | |
Upside (Analyst Target) | −56.4% | 18.1% | 51.7% | |
Fair Value Upside | Unlock | −4.3% | 9.5% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 22.61
(-56.24% Downside)
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
0.5876 / 0.094
Revenue / Forecast
176.00M / 154.20M
FAQ
What Is the SBT Ultrasonic Tech (688392) Stock Price Today?
The SBT Ultrasonic Tech stock price today is 51.67
What Stock Exchange Does SBT Ultrasonic Tech Trade On?
SBT Ultrasonic Tech is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for SBT Ultrasonic Tech?
The stock symbol for SBT Ultrasonic Tech is "688392."
What Is the SBT Ultrasonic Tech Market Cap?
As of today, SBT Ultrasonic Tech market cap is 20.50B.
What Is SBT Ultrasonic Tech's Earnings Per Share (TTM)?
The SBT Ultrasonic Tech EPS (TTM) is -0.17.
When Is the Next SBT Ultrasonic Tech Earnings Date?
SBT Ultrasonic Tech will release its next earnings report on 25 May 2025.
From a Technical Analysis Perspective, Is 688392 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has SBT Ultrasonic Tech Stock Split?
SBT Ultrasonic Tech has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.